Robert Kui
Szeged, CS, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Bimekizumab for Psoriasis: Raising the Bar in Treatment.
Journal: International journal of dermatology
Published: February 21, 2025
The Expression of Cytokines and Chemokines Potentially Distinguishes Mild and Severe Psoriatic Non-Lesional and Resolved Skin from Healthy Skin and Indicates Different Stages of Inflammation.
Journal: International journal of molecular sciences
Published: September 22, 2024
Abnormal basement membrane results in increased keratinocyte-derived periostin expression in psoriasis similar to wound healing.
Journal: Scientific reports
Published: July 21, 2023
A Randomized Controlled Trial with a Medical Device Containing Sodium Hyaluronate and Nicotinic Acid to Increase the Efficacy of Ultraviolet Phototherapy in Psoriasis.
Journal: Dermatology and therapy
Published: April 01, 2020
Presence of antidrug antibodies correlates inversely with the plasma tumor necrosis factor (TNF)-α level and the efficacy of TNF-inhibitor therapy in psoriasis.
Journal: The Journal of dermatology
Published: September 15, 2015
Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease.
Journal: World journal of gastroenterology
Published: October 11, 2013
Interleukin-1 receptors are differentially expressed in normal and psoriatic T cells.
Journal: Mediators of inflammation
Published: September 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026